[1] Zeng T, Wang Q, Fu J, et al.Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis[J]. Cell Rep, 2014, 7(3):871-882. [2] Mei Z, Zhang D, Hu B, et al.FBXO32 targets c-Myc for proteasomal degradation and inhibits c-Myc activity[J]. J Biol Chem, 2015, 290(26):16202-16214. [3] Lina W, Xin W, Yuehan Z, et al.E3 Ubiquitin ligase RNF126 regulates the progression of tongue cancer[J]. Cancer Med, 2016, 5(8):2043-2047. [4] Yang X, Pan Y, Qiu Z, et al.RNF126 as a biomarker of a poor prognosis in invasive breast cancer and CHEK1 inhibitor efficacy in breast cancer cells[J]. Clin Cancer Res, 2018, 24(7):1629-1643. [5] Yangang M, Peng L, Mengyou L, et al.A novel Zn(II) coordination polymer with a honeycomb network: inhibiting human glioma cell strains[J]. Lat Am J Pharm, 2017, 36(8):1575-1579. [6] Wang Y, Deng O, Feng Z, et al.RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression[J]. Oncogene, 2016, 35(11):1363-1372. [7] Carroll D.Genome engineering with targetable nucleases[J]. Annu Rev Biochem, 2014, 83:409-439. [8] Deveau H, Barrangou R, Garneau JE, et al.Phage response to CRISPR-encoded resistance in Streptococcus thermophilus[J]. J Bacteriol, 2008, 190:1390-1400. [9] Mussolino C, Cathomen T.RNA guides genome engineering[J]. Nat Biotechnol, 2013, 31:208-209. [10] Lieber, MR.The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway[J]. Annu Rev Biochem, 2010, 79:181-211. [11] Zhi X, Zhao D, Wang Z, et al.E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitinmediated degradation[J]. Cancer Res, 2013, 73:385-394. [12] Zheng M, Morgan-Lappe SE, Yang J, et al.Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2[J]. Cancer Res, 2008, 68:7570-7578. |